New York State Common Retirement Fund
TELO icon

New York State Common Retirement Fund’s Telomir Pharmaceuticals TELO Stock Holding History

New York State Common Retirement Fund’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,796
Closed -$38.1K – 3366
2025
Q1 		$38.1K Hold
11,796
– – ﹤0.01% 2853
2024
Q4 		$48.6K Hold
11,796
– – ﹤0.01% 2861
2024
Q3 		$75.7K Sell
11,796
-11,604
-50% -$56.6K ﹤0.01% 2725
2024
Q2 		$113K Buy
+23,400
New +$146K ﹤0.01% 2689

Other funds holding TELO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

New York State Common Retirement Fund's TELO Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Telomir Pharmaceuticals (TELO) in Q2 2025, closing a stake of 11,796 shares — an estimated $38.1K sold.

New York State Common Retirement Fund first reported a position in TELO in Q2 2024 and held it in 4 quarters. The position peaked at $113K in Q2 2024. 43 funds tracked by Wall St. Rank hold TELO as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Telomir Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 11,796 Telomir Pharmaceuticals shares in Q2 2025, an estimated $38.1K.
  • New York State Common Retirement Fund first reported a position in Telomir Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • New York State Common Retirement Fund's Telomir Pharmaceuticals position peaked at $113K in Q2 2024.
  • 43 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.